SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Norris Medicines - Quaterly Results

27 Aug 2022 Evaluate
The Sales for the quarter ended June 2022 of Rs. 9.53 million declined by -80.52% from Rs. 48.93 millions.The Net Loss for the quarter ended June 2022 is Rs. -4.39 millions as compared to Net Loss of Rs. -0.54 millions of corresponding quarter ended June 2021Operating profit Margin for the quarter ended June 2022 slipped to -1.95% as compared to 5.32% of corresponding quarter ended June 2021


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202206 202106 % Var 202206 202106 % Var 202203 202103 % Var
Sales 9.53 48.93 -80.52 9.53 48.93 -80.52 94.38 122.51 -22.96
Other Income 0.00 0.16 0.00 0.00 0.16 0.00 0.26 0.50 -48.00
PBIDT -1.95 5.32 -136.65 -1.95 5.32 -136.65 -0.46 -16.91 -97.28
Interest 0.93 4.25 -78.12 0.93 4.25 -78.12 14.82 16.34 -9.30
PBDT -2.88 1.07 -369.16 -2.88 1.07 -369.16 -15.28 -33.25 -54.05
Depreciation 1.51 1.61 -6.21 1.51 1.61 -6.21 6.57 6.67 -1.50
PBT -4.39 -0.54 712.96 -4.39 -0.54 712.96 -21.85 -39.92 -45.27
TAX 0.00 0.00 0.00 0.00 0.00 0.00 10.79 9.69 11.35
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 10.79 9.69 11.35
PAT -4.39 -0.54 712.96 -4.39 -0.54 712.96 -32.64 -49.61 -34.21
Equity 99.26 99.26 0.00 99.26 99.26 0.00 99.26 99.26 0.00
PBIDTM(%) -20.46 10.87 -288.19 -20.46 10.87 -288.19 -0.49 -13.80 -96.47

Norris Medicines Share Price

14.97 0.22 (1.49%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×